Irvine, CA, United States of America

Sukhon Likitlersuang

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Anaheim, CA (US) (2015)
  • Corona, CA (US) (2019)
  • Irvine, CA (US) (2015 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Sukhon Likitlersuang: Innovator in Ophthalmic Solutions

Introduction

Sukhon Likitlersuang is a prominent inventor based in Irvine, CA, known for his contributions to ophthalmic solutions. With a total of 9 patents, he has made significant advancements in the field of eye care, particularly in the treatment of glaucoma.

Latest Patents

Among his latest patents, Sukhon has developed preservative-free brimonidine and timolol solutions. This invention is directed towards creating solutions that lower intra-ocular pressure and treat glaucoma without the use of preservatives. Another notable patent is a two-part formulation system for ophthalmic delivery. This innovation describes ophthalmic products and methods that include a stabilizing composition containing a therapeutically active agent, which is separated from a liquid vehicle composition by a barrier. The barrier can be removed to allow the two compositions to mix, resulting in an ophthalmically acceptable liquid.

Career Highlights

Sukhon Likitlersuang is currently employed at Allergan, Inc., where he continues to push the boundaries of ophthalmic research and development. His work has been instrumental in improving treatment options for patients suffering from eye conditions.

Collaborations

Sukhon collaborates with talented professionals in his field, including Chetan Pujara and Ajay P Parashar. These partnerships enhance the innovative processes and outcomes of their projects.

Conclusion

Sukhon Likitlersuang's contributions to ophthalmic solutions exemplify the impact of innovation in healthcare. His work not only advances medical technology but also improves the quality of life for patients with glaucoma.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…